Composition And Method For Evaluating Responsiveness Of Edaravone - EP4549579
The patent EP4549579 was granted to Mitsubishi Tanabe Pharma on May 7, 2025. The application was originally filed on Jun 30, 2023 under application number EP23831626A. The patent is currently recorded with a legal status of "Request For Examination Was Made".
EP4549579
- Application Number
- EP23831626A
- Filing Date
- Jun 30, 2023
- Status
- Request For Examination Was Made
- Apr 4, 2025
- Publication Date
- May 7, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents